| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obstetric Labor, Premature | 17 | 2018 | 57 | 4.490 |
Why?
|
| Premature Birth | 12 | 2023 | 120 | 3.380 |
Why?
|
| Pregnancy Complications, Infectious | 9 | 2015 | 120 | 2.770 |
Why?
|
| Escherichia coli Infections | 9 | 2018 | 34 | 2.680 |
Why?
|
| Pregnancy | 44 | 2023 | 3064 | 2.520 |
Why?
|
| Labor, Obstetric | 3 | 2023 | 46 | 1.820 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2023 | 19 | 1.770 |
Why?
|
| Uterus | 13 | 2018 | 222 | 1.620 |
Why?
|
| Toll-Like Receptor 2 | 5 | 2020 | 35 | 1.580 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 44 | 1.510 |
Why?
|
| Placenta | 10 | 2023 | 182 | 1.380 |
Why?
|
| Myeloid Differentiation Factor 88 | 4 | 2015 | 49 | 1.280 |
Why?
|
| Inflammation | 8 | 2023 | 990 | 1.260 |
Why?
|
| Cesarean Section | 3 | 2019 | 146 | 1.220 |
Why?
|
| Macrophages | 8 | 2022 | 585 | 1.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 2 | 2018 | 4 | 1.060 |
Why?
|
| Progesterone | 6 | 2023 | 110 | 0.980 |
Why?
|
| Escherichia coli | 6 | 2018 | 611 | 0.960 |
Why?
|
| Streptococcus agalactiae | 3 | 2015 | 11 | 0.950 |
Why?
|
| Streptococcal Infections | 3 | 2015 | 55 | 0.920 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 232 | 0.920 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 343 | 0.910 |
Why?
|
| Female | 51 | 2023 | 46855 | 0.900 |
Why?
|
| Isothiocyanates | 1 | 2022 | 7 | 0.840 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.840 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 625 | 0.820 |
Why?
|
| Toll-Like Receptor 4 | 5 | 2015 | 91 | 0.820 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2022 | 4 | 0.820 |
Why?
|
| Cerclage, Cervical | 1 | 2022 | 5 | 0.820 |
Why?
|
| Mice | 26 | 2022 | 11932 | 0.780 |
Why?
|
| Perineum | 2 | 2014 | 36 | 0.760 |
Why?
|
| Myometrium | 2 | 2020 | 51 | 0.730 |
Why?
|
| Interleukin-1 | 4 | 2006 | 72 | 0.720 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 8 | 0.690 |
Why?
|
| Endometritis | 1 | 2019 | 2 | 0.690 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.690 |
Why?
|
| Genital Diseases, Female | 1 | 2020 | 24 | 0.680 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 24 | 0.670 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 21 | 0.670 |
Why?
|
| Poly I-C | 4 | 2015 | 19 | 0.630 |
Why?
|
| Receptors, Notch | 2 | 2015 | 127 | 0.600 |
Why?
|
| Anger | 1 | 2018 | 81 | 0.580 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 205 | 0.580 |
Why?
|
| Animals | 31 | 2022 | 27691 | 0.580 |
Why?
|
| Patients | 1 | 2018 | 104 | 0.570 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2006 | 11 | 0.570 |
Why?
|
| Peptidoglycan | 4 | 2015 | 31 | 0.570 |
Why?
|
| Signal Transduction | 9 | 2015 | 3426 | 0.570 |
Why?
|
| Cognition | 1 | 2021 | 587 | 0.550 |
Why?
|
| Infant, Newborn | 6 | 2023 | 2501 | 0.540 |
Why?
|
| Toll-Like Receptors | 4 | 2011 | 93 | 0.530 |
Why?
|
| Vaginal Smears | 1 | 2016 | 71 | 0.520 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 53 | 0.520 |
Why?
|
| Lipopolysaccharides | 5 | 2018 | 295 | 0.510 |
Why?
|
| Patient Advocacy | 1 | 2016 | 53 | 0.510 |
Why?
|
| Receptors, Progesterone | 2 | 2023 | 176 | 0.490 |
Why?
|
| Medical Errors | 1 | 2016 | 115 | 0.490 |
Why?
|
| Obstetrics | 1 | 2016 | 122 | 0.470 |
Why?
|
| Platelet Activating Factor | 1 | 2014 | 53 | 0.470 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2014 | 51 | 0.470 |
Why?
|
| Extraction, Obstetrical | 1 | 2014 | 7 | 0.460 |
Why?
|
| Humans | 31 | 2023 | 90568 | 0.460 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 34 | 0.450 |
Why?
|
| Inflammation Mediators | 5 | 2020 | 155 | 0.450 |
Why?
|
| Membrane Proteins | 4 | 2015 | 1231 | 0.450 |
Why?
|
| Neutrophils | 1 | 2015 | 313 | 0.440 |
Why?
|
| RNA, Messenger | 4 | 2015 | 2030 | 0.440 |
Why?
|
| Mice, Knockout | 8 | 2015 | 2033 | 0.430 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 298 | 0.420 |
Why?
|
| Autophagy | 1 | 2015 | 160 | 0.420 |
Why?
|
| Obstetrical Forceps | 2 | 2014 | 9 | 0.420 |
Why?
|
| Vacuum Extraction, Obstetrical | 2 | 2014 | 6 | 0.420 |
Why?
|
| Quality of Health Care | 1 | 2016 | 387 | 0.420 |
Why?
|
| Fetus | 5 | 2015 | 232 | 0.420 |
Why?
|
| Education, Medical | 1 | 2016 | 244 | 0.420 |
Why?
|
| Bacterial Infections | 2 | 2005 | 185 | 0.410 |
Why?
|
| Lacerations | 2 | 2014 | 27 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 9 | 2017 | 3273 | 0.400 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2010 | 9 | 0.370 |
Why?
|
| Disease Models, Animal | 9 | 2017 | 2407 | 0.370 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 604 | 0.370 |
Why?
|
| Cyclooxygenase 2 | 4 | 2015 | 99 | 0.360 |
Why?
|
| Meteorological Concepts | 1 | 2010 | 2 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 348 | 0.350 |
Why?
|
| Parturition | 1 | 2010 | 22 | 0.350 |
Why?
|
| Gestational Age | 4 | 2023 | 327 | 0.340 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 25 | 0.340 |
Why?
|
| Caspase Inhibitors | 1 | 2009 | 33 | 0.340 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 53 | 0.340 |
Why?
|
| Mice, Inbred C3H | 5 | 2017 | 371 | 0.330 |
Why?
|
| Gene Expression | 4 | 2015 | 1312 | 0.320 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 146 | 0.320 |
Why?
|
| Physicians | 1 | 2016 | 690 | 0.320 |
Why?
|
| Seasons | 1 | 2010 | 242 | 0.310 |
Why?
|
| Interleukin-6 | 2 | 2015 | 268 | 0.310 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2005 | 6 | 0.310 |
Why?
|
| Labor Presentation | 1 | 2008 | 4 | 0.310 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 36 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 705 | 0.300 |
Why?
|
| Cytokines | 5 | 2015 | 813 | 0.290 |
Why?
|
| Vagina | 3 | 2012 | 176 | 0.270 |
Why?
|
| Logistic Models | 2 | 2021 | 1216 | 0.270 |
Why?
|
| Internship and Residency | 1 | 2016 | 1066 | 0.270 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1873 | 0.270 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 67 | 0.260 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 43 | 0.260 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2022 | 70 | 0.260 |
Why?
|
| Fetal Death | 3 | 2015 | 57 | 0.260 |
Why?
|
| Wound Healing | 3 | 2012 | 365 | 0.250 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 289 | 0.250 |
Why?
|
| Mice, Mutant Strains | 5 | 2013 | 231 | 0.250 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 82 | 0.240 |
Why?
|
| Up-Regulation | 3 | 2018 | 728 | 0.240 |
Why?
|
| NF-kappa B | 3 | 2015 | 469 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 434 | 0.240 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 982 | 0.230 |
Why?
|
| Retrospective Studies | 5 | 2023 | 9323 | 0.230 |
Why?
|
| Adult | 8 | 2021 | 26940 | 0.220 |
Why?
|
| Hydroxyprogesterones | 1 | 2023 | 22 | 0.220 |
Why?
|
| Enzymes | 1 | 2003 | 48 | 0.210 |
Why?
|
| Amniotic Fluid | 1 | 2023 | 30 | 0.210 |
Why?
|
| Phenols | 1 | 2022 | 41 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2892 | 0.200 |
Why?
|
| Cell Line | 2 | 2020 | 2505 | 0.200 |
Why?
|
| Risk Factors | 3 | 2021 | 5580 | 0.200 |
Why?
|
| Cervix Uteri | 1 | 2022 | 71 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2012 | 89 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 923 | 0.200 |
Why?
|
| Pregnancy, Animal | 1 | 2002 | 58 | 0.200 |
Why?
|
| Clinical Competence | 2 | 2018 | 796 | 0.190 |
Why?
|
| Pregnancy Trimester, First | 1 | 2021 | 63 | 0.180 |
Why?
|
| Bias | 1 | 2021 | 135 | 0.180 |
Why?
|
| Torque teno virus | 1 | 2020 | 1 | 0.170 |
Why?
|
| Chlorhexidine | 1 | 2019 | 2 | 0.170 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 9 | 0.170 |
Why?
|
| Mass Screening | 2 | 2022 | 646 | 0.170 |
Why?
|
| Glucose | 1 | 2022 | 633 | 0.170 |
Why?
|
| Uncertainty | 1 | 2020 | 75 | 0.160 |
Why?
|
| Uterine Diseases | 2 | 2013 | 19 | 0.160 |
Why?
|
| Diagnostic Errors | 1 | 2020 | 160 | 0.160 |
Why?
|
| Skin | 2 | 2012 | 590 | 0.160 |
Why?
|
| Chorioamnionitis | 2 | 2017 | 21 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2022 | 846 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 56 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1991 | 0.150 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 309 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2021 | 775 | 0.140 |
Why?
|
| Interleukins | 1 | 2018 | 132 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 285 | 0.140 |
Why?
|
| Fraud | 1 | 2016 | 6 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 364 | 0.130 |
Why?
|
| Papanicolaou Test | 1 | 2016 | 38 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 225 | 0.130 |
Why?
|
| Malpractice | 1 | 2016 | 57 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2015 | 680 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1806 | 0.130 |
Why?
|
| Polynucleotides | 1 | 2015 | 17 | 0.130 |
Why?
|
| Transcription Factor HES-1 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Decidua | 1 | 2015 | 19 | 0.130 |
Why?
|
| Carrier State | 1 | 2015 | 39 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2020 | 4345 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1607 | 0.120 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 74 | 0.120 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 22 | 0.120 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2015 | 12 | 0.120 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2015 | 21 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 121 | 0.120 |
Why?
|
| Phagosomes | 1 | 2015 | 39 | 0.120 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 87 | 0.120 |
Why?
|
| Recurrence | 2 | 2015 | 1162 | 0.120 |
Why?
|
| Maternal Age | 1 | 2014 | 45 | 0.120 |
Why?
|
| Caspases | 2 | 2018 | 155 | 0.120 |
Why?
|
| Cyclooxygenase 1 | 2 | 2005 | 5 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 182 | 0.120 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 35 | 0.120 |
Why?
|
| Male | 6 | 2018 | 42931 | 0.120 |
Why?
|
| Heterozygote | 1 | 2015 | 373 | 0.120 |
Why?
|
| Parity | 1 | 2014 | 97 | 0.120 |
Why?
|
| Lysosomes | 1 | 2015 | 116 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 278 | 0.110 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 283 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 177 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 806 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 441 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 90 | 0.110 |
Why?
|
| Proton-Translocating ATPases | 1 | 2013 | 23 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 198 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 184 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2005 | 219 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 106 | 0.110 |
Why?
|
| RNA | 2 | 2009 | 587 | 0.100 |
Why?
|
| Ligands | 2 | 2013 | 453 | 0.100 |
Why?
|
| Colpotomy | 1 | 2012 | 4 | 0.100 |
Why?
|
| Complement C5 | 1 | 2012 | 14 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 29 | 0.100 |
Why?
|
| Menopause | 1 | 2012 | 80 | 0.100 |
Why?
|
| Surgeons | 1 | 2016 | 252 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 558 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 683 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2013 | 437 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2011 | 141 | 0.090 |
Why?
|
| Peroxidase | 3 | 2017 | 51 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 154 | 0.090 |
Why?
|
| Gene-Environment Interaction | 1 | 2011 | 118 | 0.090 |
Why?
|
| Extraembryonic Membranes | 1 | 2009 | 8 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 122 | 0.080 |
Why?
|
| Ovarian Follicle | 1 | 2009 | 73 | 0.080 |
Why?
|
| Calpain | 1 | 2009 | 113 | 0.080 |
Why?
|
| Receptors, Interleukin | 1 | 2009 | 37 | 0.080 |
Why?
|
| Illinois | 1 | 2010 | 491 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 303 | 0.080 |
Why?
|
| Ovariectomy | 2 | 2012 | 82 | 0.080 |
Why?
|
| Teichoic Acids | 1 | 2007 | 18 | 0.070 |
Why?
|
| Apoptosis | 2 | 2013 | 1723 | 0.070 |
Why?
|
| Rabbits | 3 | 2012 | 641 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 888 | 0.070 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2006 | 5 | 0.070 |
Why?
|
| Cervical Ripening | 1 | 2006 | 4 | 0.070 |
Why?
|
| Infant | 2 | 2023 | 3183 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1240 | 0.060 |
Why?
|
| Fetal Weight | 2 | 2017 | 15 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2005 | 69 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6812 | 0.060 |
Why?
|
| Organ Size | 2 | 2017 | 374 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 546 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2005 | 1583 | 0.060 |
Why?
|
| Gravidity | 1 | 2023 | 7 | 0.060 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2023 | 31 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2003 | 42 | 0.050 |
Why?
|
| Proteomics | 1 | 2005 | 241 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2424 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 275 | 0.050 |
Why?
|
| Foam Cells | 1 | 2002 | 17 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 4059 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1882 | 0.050 |
Why?
|
| Genotype | 2 | 2003 | 1855 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1015 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 260 | 0.040 |
Why?
|
| Cholesterol | 1 | 2002 | 362 | 0.040 |
Why?
|
| Genomics | 1 | 2005 | 784 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 2018 | 49 | 0.040 |
Why?
|
| Uterine Cervicitis | 1 | 2017 | 4 | 0.040 |
Why?
|
| Biomarkers | 2 | 2013 | 1797 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2335 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2013 | 20 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 25 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 52 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 97 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 7 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 327 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 37 | 0.020 |
Why?
|
| Calcinosis | 1 | 2013 | 230 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 112 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 200 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 697 | 0.020 |
Why?
|
| Mutation | 1 | 2002 | 4184 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 680 | 0.020 |
Why?
|
| Urban Population | 1 | 2011 | 225 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 294 | 0.020 |
Why?
|
| Young Adult | 2 | 2011 | 6425 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 827 | 0.020 |
Why?
|
| Cholates | 1 | 2002 | 1 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 12 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 171 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2002 | 137 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 437 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9353 | 0.010 |
Why?
|